Lamotrigine

ArticlesMedicine Compliance Aid StabilityLactation Safety Information ·
96195007

Articles

Medicine Compliance Aid Stability

genericNon-proprietary

Non-proprietary
generic
Tablets 25mg, 50mg, 100mg, 200mg,
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Store in airtight containers.
23 February 2015

LamictalGlaxoSmithKline UK

GlaxoSmithKline UK
Lamictal
Tablets dispersible 2mg, 5mg, 25mg, 100mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Unsuitable for MCA as dispersible tablets.
23 February 2015

genericNon-proprietary

Non-proprietary
generic
Tablets dispersible 5mg, 25mg, 100mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Unsuitable.
23 February 2015

LamictalGlaxoSmithKline UK

GlaxoSmithKline UK
Lamictal
Tablets 25mg, 50mg, 100mg, 200mg,
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
No special requrements for storage
23 February 2015

Lactation Safety Information

For epilepsy

For epilepsy
Suitable alternative antiepileptic
Significant published evidence of use in breastfeeding
Significant amounts in breast milk
Long half-life increases risk of accumulation in breastfed infants
Mild thrombocytosis reported in some infants. Single case reports of severe apnoea, reversible anaemia and neutropenia in breastfed infants possibly associated with lamotrigine
Monitor infant for rash, apnoea, drowsiness and poor feeding. If rash occurs breastfeeding should be withheld until the cause can be established.
9 January 2020